Expand KRYS Menu
KRYS MENU

KRYS Latest Press Releases

-- February 17, 2026 --

Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results Globe Newswire 7:00 AM

-- February 10, 2026 --

Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 Globe Newswire 8:00 AM

-- February 9, 2026 --

Krystal Biotech Announces RMAT Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer Globe Newswire 8:00 AM

-- January 11, 2026 --

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 1:00 PM

-- January 8, 2026 --

Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis Globe Newswire 4:01 PM

-- January 7, 2026 --

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis Globe Newswire 4:05 PM

-- January 5, 2026 --

Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:00 AM

-- November 26, 2025 --

Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference Globe Newswire 8:00 AM

-- November 3, 2025 --

Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results Globe Newswire 7:00 AM

-- October 21, 2025 --

Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025 Globe Newswire 8:00 AM

-- October 14, 2025 --

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes